# FDA Inspection 1168619 - Madhavi Ampajwala, M.D. - April 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/madhavi-ampajwala-md/33762e1a-7cba-4e19-953e-d0915ae8cb62
Source feed: FDA_Inspections

> FDA Inspection 1168619 for Madhavi Ampajwala, M.D. on April 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168619
- Company Name: Madhavi Ampajwala, M.D.
- Inspection Date: 2022-04-28
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1168619 - 2022-04-28](https://www.keypedia.com/records/fda_inspections/madhavi-ampajwala-md/726fd040-444c-4d82-a76a-8bd7d266ac26)

Company: https://www.keypedia.com/companies/madhavi-ampajwala-md/15b3c4d6-5d82-484f-8311-6076328c58c3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d